EVALUATION OF THE EFFECT AND SAFETY OF PONATINIB AS THIRD LINETREATMENT FOR PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE
Bildiriler > Yayınlanmadı · 2016
Yazarlar: PÜSEM PATIR, Ayşe Uysal, Mustafa Duran, Nur SOYER, Filiz VURAL, Güray SAYDAM
AHOS 2016, Uluslararası, Sözlü Sunum, Yayınlanmadı, 2016-2016, cilt 1, ss 34-